VRTX
Valuation Healthcare · Biotechnology Data as of 2026-03-31P/E Ratio · Metrics
P/E Ratio
27.74
PEG Ratio
0.34
Dividend Yield
-
Gross Margin
86.85%
Net Margin
34.53%
Revenue CAGR 3Y
7.94%
ROE
21.31%
ROA
15.58%
Buyback Yield
-0.08%
Current Ratio
3.02
Magic Earn Yield
-
Altman Z-Score
-
Fair Value River
Score
Valuation 67
Profitability 65
Growth 26
Health 100
Yield 0